Alzheimer’s disease: Transcranial Pulse Stimulation (TPS) with the NEUROLITH system significantly improves brain performance of patients

Bowling loads and injury risk in male first class county cricket: Is ‘differential load’ an alternative to the acute-to-chronic workload ratio?
10 janvier 2020
Medication information and supply behaviours in elite and developing athletes
17 janvier 2020

Alzheimer’s disease: Transcranial Pulse Stimulation (TPS) with the NEUROLITH system significantly improves brain performance of patients

In 2018, Transcranial Pulse Stimulation (TPS®) with the NEUROLITH® system was the first, and hitherto only, procedure of its kind to obtain market authorization for the »treatment of the central nervous system of patients with Alzheimer’s disease«. TPS® was developed by STORZ MEDICAL in collaboration with a team of researchers from the Medical University of Vienna (Department of Neurology), led by Professor Roland Beisteiner, and Dr. Henning Lohse-Busch, Rheintalklinik, Bad Krozingen. In December 2019, the prestigious journal »Advanced Science« published a study, in which Beisteiner et al. evaluate the method and present first treatment results. The presented data shows that it is possible to improve brain performance with TPS® and that there is a long-term effect.

Powered by WPeMatico

Comments are closed.